<- Go Home
Fagron NV
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments. It also offers education and professional development of prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Market Cap
EUR 1.4B
Volume
56.2K
Cash and Equivalents
EUR 115.0M
EBITDA
EUR 146.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 395.7M
Profit Margin
45.38%
52 Week High
EUR 20.15
52 Week Low
EUR 15.14
Dividend
1.86%
Price / Book Value
2.73
Price / Earnings
17.09
Price / Tangible Book Value
61.55
Enterprise Value
EUR 1.6B
Enterprise Value / EBITDA
10.28
Operating Income
EUR 130.0M
Return on Equity
16.65%
Return on Assets
7.77
Cash and Short Term Investments
EUR 115.9M
Debt
EUR 386.7M
Equity
EUR 505.4M
Revenue
EUR 872.0M
Unlevered FCF
EUR 49.4M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium